CLINICAL AND SONOGRAPHIC ASSESSMENT OF SYNOVITIS ACTIVITY IN PATIENTS WITH KNEE OSTEOARTHRITIS DURING THERAPY

The inflammatory process in the synovial membrane (SM), which may be a main cause of chronic pain in many patients, is one of the most significant components in the pathogenesis of osteoarthritis (OA).Objective: to study the time course of clinical and sonographic changes in patients with knee OA wh...

Full description

Bibliographic Details
Published in:	Научно-практическая ревматология
Main Authors:	A. V. Petrov, A. A. Zayaeva
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2016-02-01
Subjects:	knee osteoarthritis synovitis sonography glucosamine sulfate chondroitin sulfate diacerein
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2150

Similar Items

The Role of Glucosamine Chondrotin Sulfate in the Treatment of Osteoarthritis of Knee
by: Sadeq A. AlMukhtar, et al.
Published: (2013-01-01)

Assessment of Compliance of Glucosamine and Chondroitin Sulfate in Patients with Early Osteoarthritis of the Knee
by: Ajit Prakash Bhaskarwar, et al.
Published: (2023-07-01)

Assessment of Compliance of Glucosamine and Chondroitin Sulfate in Patients with Early Osteoarthritis of Knee
by: Parikshat Gopal, et al.
Published: (2023-12-01)

Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-08-01)

Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-08-01)

Comparative Study Between The Clinical Effects of Glucosamine/Gingko Biloba & Glucosamine/Chondroitin in Treatment of Knee Osteoarthritis
by: Mohammed D. Al-Rekabi
Published: (2014-08-01)

SLOW-ACTING ANTI-ARTHROSIS MEDICATIONS FOR THE TREATMENT OF OSTEOARTHRITIS
by: M. S. SVETLOVA
Published: (2016-12-01)

CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS
by: E. S. Tsvetkova, et al.
Published: (2015-03-01)

The effect of glucosamine, chondroitin and harpagophytum procumbens on femoral hyaline cartilage thickness in patients with knee osteoarthritis– An MRI versus ultrasonography study
by: Florentin A. Vreju, et al.
Published: (2019-05-01)

Efficacy of various regimens of bioactive marine fish concentrate, glucosamine sulfate, and chondroitin sulfate in treating knee osteoarthritis
by: D.G. Rekalov, et al.
Published: (2024-12-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

Showiness or efficiency: what to choose?
by: D.G. Rekalov, et al.
Published: (2013-08-01)

Effectiveness of Glucosamine and Chondroitin Sulfate Combination in Patients with Primary Osteoarthritis
by: Laszlo IRSAY, et al.
Published: (2010-12-01)

The management of patients with osteoarthritis by a primary care physician: focus on efficacy and safety
by: M. S. Svetlova
Published: (2018-05-01)

A new look at back pain treatment in light of the latest ESCEO guidelines
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01)

The effect of using chondroitin sulfate in osteoarthritis of the knee
by: Ziemowit Żaba, et al.
Published: (2023-01-01)

Knee osteoarthrosis: Clinical presentation, diagnosis, treatment
by: Vladimir Vasilyevich Badokin
Published: (2013-10-01)

Effectiveness and Safety of SYSADOAs Used in Eastern and Western Regions for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials—SYSADOAs Are Effective and Safe for Knee OA
by: Yong-Beom Park, et al.
Published: (2025-02-01)

Use of Artra and Artra MSM Forte in osteoarthritis of the large joints and lowback pain
by: E. P. Sharapova, et al.
Published: (2019-06-01)

The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)

Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01)

Combined chondroprotectors in the treatment of osteoartritis
by: L.V. Derymedvid, et al.
Published: (2018-02-01)

On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2024-08-01)

Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
by: Vladimir Vasil'evich Badokin, et al.
Published: (2011-09-01)

Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
by: Vladimir Vasil'evich Badokin, et al.
Published: (2011-09-01)

Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01)

Combination therapy for exacerbations of pain in osteoarthritis with non-fixed combinations
by: Anton V. Naumov, et al.
Published: (2025-01-01)

Osteoarthritis: management strategies depending on the location of lesions
by: N. A. Shostak, et al.
Published: (2022-07-01)

From misconceptions to reasonable osteoarthritis patients therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-07-01)

Evaluation of the efficacy and safety of a combination of chondroitin sulfate and glucosamine sulfate for knee and hip osteoarthritis in real clinical practice
by: A. E. Karateev, et al.
Published: (2020-11-01)

Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis
by: Yong Sun, et al.
Published: (2020-04-01)

On the use of chondroitin sulfate, glucosamine sulfate and undenatured type II collagen for back and limb pain and osteoarthritis
by: O. A. Gromova, et al.
Published: (2022-12-01)

Multimorbidity in osteoarthritis and pleiotropic effects of slow-acting symptomatic drugs. Resolution of the multidisciplinary International Expert Council
by: V. I. Mazurov, et al.
Published: (2023-10-01)

ON ROLE OF CHONDROPROTECTIVE AGENTS IN OSTEOARTHRITIS: ON THE WAY TO THE EVIDENCE-BASED MEDICINE
by: S. V. Jargin
Published: (2016-11-01)

Treatment in patients with osteoarthritis at different sites: Place of slow-acting drugs
by: N. V. Chichasova, et al.
Published: (2015-06-01)

Efficacy of combination chondroitin sulfate plus glucosamine hydrochloride in osteoarthritis: A systematic review
by: Anton V. Naumov, et al.
Published: (2024-12-01)

Symptom-modifying slow-acting drugs in the treatment of osteoarthritis: from molecule to clinical effect (a pharmacologist's view)
by: A. S. Dukhanin
Published: (2018-06-01)

Effect of chondroitin sulfate on cartilage volume loss and subchondral bone marrow lesions in osteoarthritis knee
by: Mohammad H Elgawish, et al.
Published: (2015-01-01)

Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01)

Russian experience with injectable chondroitin sulfate and glucosamine sulfate: a review of clinical trials
by: A. E. Karateev, et al.
Published: (2018-04-01)